Vitruvias Therapeutics
Tracked across 1 events · 6 articles · First seen Aug 25, 2026 · Last active Aug 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Voluntarily recalled one lot of thyroid tablets due to superpotency, potentially affecting its reputation and sales, though no adverse events reported.
Aug 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Vitruvias Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard